Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gilead's Mansuri Joins Sanofi

This article was originally published in Scrip

Executive Summary

Sanofi has appointed Muzammil Mansuri member of the executive committee and executive vice president, strategy and business development. Mansuri joins Sanofi from Gilead Sciences where he most recently was senior vice president, research and development strategy and corporate development. He brings over 35 years' experience to the company and started out as a research scientist at Shell Research Ltd. Previously he held various R&D roles in Bristol-Myers Company and was chair and CEO at CGI Pharmaceuticals.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts